European Journal of Epidemiology

, Volume 17, Issue 4, pp 385–390 | Cite as

Sexual behavior and the prevalence of Chlamydia trachomatis infection in asymptomatic students in Germany and Spain

  • C. Stock
  • F. Guillén-Grima
  • L. Prüfer-Krämer
  • I. Serrano-Monzo
  • B. Marin-Fernandez
  • I. Aguinaga-Ontoso
  • A. Krämer


This study aimed to assess patterns of sexual activity, preventive behaviors, contraceptive use, and the prevalence of chlamydia infection in student populations from two countries. 188 asymptomatic students of the University of Bielefeld, Germany and 590 students of the Navarra Public University, Spain were surveyed using a standardized self-administered questionnaire. Urine samples were analyzed by ligase chain reaction technique for chlamydia infection. Compared to German students, Spanish students were less likely to have more than one sex partner within the last 12 months (OR: 0.62; CI: 0.46–0.83), to have sexual intercourse more than one time per week (OR: 0.70; CI: 0.52–0.93) and to use oral contraceptives (OR: 0.16; CI: 0.10–0.26). They reported a higher use of condoms (OR: 2.93; CI: 2.01–4.27) and were more likely to always use condoms with a new sex partner (OR: 2.47; CI: 1.72–3.53). The prevalence of chlamydia infection was considerably higher in German students (4.8% in females; 2.2% in males) than in Spanish students, where no case was found. The higher frequency of sexual activity, a higher engagement in risk-taking sexual behavior and the lower use of barrier contraceptives may contribute to the higher prevalence of chlamydia infection in German students.

Chlamydia trachomatis infection Risk-taking behavior Sexual behavior Sexually transmitted diseases University students 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Paavonen J, Wolner-Hanssen P. Chlamydia trachomatis: A major threat to human reproduction. Hum Reprod 1989; 4: 111–124.Google Scholar
  2. 2.
    Cates W, Rolfs RT, Aral SO. Sexually transmitted diseases, pelvic inflammatory disease, and infertility: An epidemiologic update. Epidemiol Rev 1990; 12: 199–220.Google Scholar
  3. 3.
    Westström LV. Sexually transmitted diseases and infertility. Sex Transm Dis 1994; 21: 32–37.Google Scholar
  4. 4.
    Koch J, Kirschner W, Schäfer A. Bestimmung der Prävalenz genitaler HPV-und Chlamydia-trachomatis-Infektionen in einem repräsentativen Querschnítt der weiblichen Normalbevölkerung in Berlin. Infektions-epidemiologische Forschung 1997; 2: 1–7.Google Scholar
  5. 5.
    Nayygar KC, Cummings M, Weber J, et al. Prevalence of genital pathogens among female prostitutes in New York City and in Rotterdam. Sex Transm Dis 1986; 4: 105–107.Google Scholar
  6. 6.
    Schachter J, Stamm WE, Quinn T, Andrews WW, Burczak JD, Lee HH. Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix. J Clin Microbiol 1994; 32: 2540–2543.Google Scholar
  7. 7.
    Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for chlamydial infection. N Engl J Med 1996; 334: 1362–1366.Google Scholar
  8. 8.
    Svensson LO, Mares I, Olsson SE, Nordstrom ML. Screening for Chlamydia trachomatis infections in women and aspects of the laboratory diagnostics. Acta Obstet Gynaecol Scand 1991; 70: 587–590.Google Scholar
  9. 9.
    Herrmann B, Egger M. Genital Chlamydia trachomatis infections in Uppsala County, Sweden, 1983–1993, declining rates for how much longer? Sex Transm Dis 1996; 22: 253–260.Google Scholar
  10. 10.
    Vuylsteke B, Vandenbruane M, Vandenbalcke P, Van Dyck E, Laga M. Chlamydia trachomatis prevalence and sexual behaviour among female adolescents in Belgium. Sex Transm Infect 1999; 75: 152–155.Google Scholar
  11. 11.
    Rosalez M, Dominguez V, Bonacho I, Vidal X. Epidemiolgia de Chlamydia trachomatis en una problacion que acude a un centro de planificacion familiar. Revista Clinica Española 1993; 192: 424–427.Google Scholar
  12. 12.
    Mariñas JJ, Rego ME, Rosales M, Castro MI, Bouzas E. Evaluacion de la efectividad de un programa de deteccion de infeccion asintomatica por Chlamydia trachomatis en mujeres. Revista Española de Salud Publica 1997; 71: 27–34.Google Scholar
  13. 13.
    Svensson LO, Mares I, Mardh PA, Olsson SE. Screening voided urine for Chlamydia trachomatis in asymptomatic adolescent females. Acta Obstet Gynecol Scand 1994; 73: 63–66.Google Scholar
  14. 14.
    Weinstock HS, Bolan GA, Kohn K, Balladares C, Back A, Oliva G. Chlamydia trachomatis infections in women: A need for universal screening in high prevalence populations? Am J Epidemiol 1992; 135: 41–47.Google Scholar
  15. 15.
    Gaydos CA, Crotchfelt KA, Howell MR, Kralian S, Hauptman P, Quinn TC. Molecular amplification assays to detect chlamydial infections in urine specimen from high school female students and to monitor the persistence of chlamydial DNA after therapy. J Infect Dis 1998; 177: 417–424.Google Scholar
  16. 16.
    Goertzel TG, Bluebond-Langner M. What is the impact of a campus AIDS education course? J Am College Health 1991; 40: 87–92.Google Scholar
  17. 17.
    Katzman E, Mulholland M, Sutherland E. College students and AIDS: A preliminary survey of knowledge, attitudes, and behavior. J Am College Health 1988; 37: 127–130.Google Scholar
  18. 18.
    Bundeszentrale für gesundheitliche Aufklärung. Repräsentativerhebungen “AIDS im öffentlichen Bewußtsein.” Bundeszentrale für gesundheitliche Aufklärung, Bonn, 1998.Google Scholar
  19. 19.
    Han Y, Morse DL, Laurence CE, Murphy D, Hipp S. Risk profile for chlamydia infection in women from public health clinics in New York State. J Commun Health 1993; 18: 1–9.Google Scholar
  20. 20.
    Rogstad KE, Bates SM, Partridge S, et al. The prevalence of Chlamydia trachomatis infection in male undergraduates: A postal survey. Sex Transm Inf 2001; 77: 111–113.Google Scholar
  21. 21.
    Registro de Cáncer de Navarra. Incidencia de Cáncer en Navarra 1993–1994. Anales del Sistema Sanitario de Navarra 1999; 22: 383–392.Google Scholar
  22. 22.
    Anttila T, Saikku P, Koskela P, et al. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 2001; 3: 47–51.Google Scholar
  23. 23.
    Burstein GR, Waterfield G, Joffe A, Zenilman JM, Quinn TC, Gaydos CA. Screening for genorrhea and chlamydia by DNA amplification in adolescents attending middle school health centers. Sex Transm Dis 1998; 25: 395–402.Google Scholar
  24. 24.
    Marrazzo JM, White CL, Krekeler B, et al. Community-based urine screening for Chlamydia trachomatis with ligase chain reaction assay. Ann Int Med 1997; 127: 796–803.Google Scholar
  25. 25.
    Rietmeijer CA, Yamaguchi KJ, Oritz CG, et al. Feasibility and yield of screening urine for Chlamydia trachomatis by polymerase chain reaction among high-risk male youth in field-based and other non-clinical settings. Sex Transm Dis 1997; 24: 429–435.Google Scholar
  26. 26.
    Henry-Sachet J, Sluzhinska A, Serfaty D. Chlamydia trachomatis screening in family planning centers: A review of cost/benefit evaluations in different countries. Eur J Contraception Reprod Health Care 1996; 1: 301–309.Google Scholar

Copyright information

© Kluwer Academic Publishers 2001

Authors and Affiliations

  • C. Stock
    • 1
  • F. Guillén-Grima
    • 2
  • L. Prüfer-Krämer
    • 1
  • I. Serrano-Monzo
    • 3
  • B. Marin-Fernandez
    • 2
  • I. Aguinaga-Ontoso
    • 3
  • A. Krämer
    • 1
  1. 1.School of Public HealthUniversity of BielefeldBielefeldGermany
  2. 2.Department of Health SciencesNavarra Public UniversityPamplona
  3. 3.School of NursingUniversity of NavarraPamplonaSpain

Personalised recommendations